Melinta Therapeutics, LlcUsage: ORBACTIV (oritavancin) treats acute bacterial skin and skin structure infections (ABSSSI) in adults caused by susceptible Gram-positive bacteria, including MRSA, Streptococcus species, and vancomycin-susceptible Enterococcus faecalis.